Cancer is associated with a 2.7 higher risk for intravitreal injection therapy in patients with age-related, diabetic, or vascular occlusive macular edema

Sirpa Loukovaara; Jari Haukka

doi:10.1111/aos.14546

Cancer is associated with a 2.7 higher risk for intravitreal injection therapy in patients with age-related, diabetic, or vascular occlusive macular edema

Research output: Contribution to journal › Letter › Scientific

Original language	English
Journal	Acta Ophthalmologica
Number of pages	1
ISSN	1755-375X
DOIs	https://doi.org/10.1111/aos.14546
Publication status	E-pub ahead of print - 24 Aug 2020
MoE publication type	B1 Journal article

Fields of Science

RETINOPATHY

Access to Document

10.1111/aos.14546

Cite this

@article{766ec38dd3ec4034a5ad3765a3da7d1e,

title = "Cancer is associated with a 2.7 higher risk for intravitreal injection therapy in patients with age-related, diabetic, or vascular occlusive macular edema",

keywords = "RETINOPATHY",

author = "Sirpa Loukovaara and Jari Haukka",

year = "2020",

month = aug,

day = "24",

doi = "10.1111/aos.14546",

language = "English",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "Wiley",

}

TY - JOUR

T1 - Cancer is associated with a 2.7 higher risk for intravitreal injection therapy in patients with age-related, diabetic, or vascular occlusive macular edema

AU - Loukovaara, Sirpa

AU - Haukka, Jari

PY - 2020/8/24

Y1 - 2020/8/24

KW - RETINOPATHY

U2 - 10.1111/aos.14546

DO - 10.1111/aos.14546

M3 - Letter

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-375X

ER -